Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –– Extends ...
12h
Collegium Pharmaceutical, Inc.: Collegium Completes Acquisition of AZSTARYS from Corium Therapeutics
Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio - - Extends Collegium's Long-Term Revenue Outlook; AZSTARYS has Expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results